Complications of eustachian tube balloon dilation: Manufacturer and User Facility Device Experience (MAUDE) database analysis and literature review.

Authors:
Chisolm PF; Hakimi AA; Maxwell JH; Russo ME.

Journal:
Laryngoscope Investig Otolaryngol

Publication Year: 2023

DOI:
10.1002/lio2.1185

PMCID:
PMC10731503

PMID:
38130257

View on PubMed View on PMC View Publisher
Journal Information

Full Title: Laryngoscope Investig Otolaryngol

Abbreviation: Laryngoscope Investig Otolaryngol

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Otorhinolaryngology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
ACE2 and TAS2R38 receptor expression in pediatric and adult patients in the nasal and oral cavity.
Franks ZG; Nandakumar K; Santhanam L and 3 more (2024) - Transparency Score: 4/6
A comparative analysis of laryngeal nerve damage in patients with idiopathic vocal cord paralysis e…
Liu XH; Yan J; Li N and 8 more (2024) - Transparency Score: 3/6
A quantitative analysis of Twitter ("X") trends in the discussion of rhinoplasty.
Mandava S; Oyer SL; Park SS. (2024) - Transparency Score: 2/6
A response to a single cadaver study assessing the efficacy of two commercially available devices f…
Gould SJ. (2024) - Transparency Score: 3/6
Factors associated with successful electrolarynx use after total laryngectomy, a multi-institutiona…
Pan C; Andrews LIB; Johnson E and 2 more (2024) - Transparency Score: 3/6
View All Papers from This Journal
Transparency Score
4/6
66.7% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Evidence found in paper:

"data s1: supporting information."

Code Sharing
Evidence found in paper:

"CONFLICT OF INTEREST STATEMENT The authors have no conflicts of interest to report."

Evidence found in paper:

"This research did not receive any specific grant from funding agencies in the public, commercial, or not‐for‐profit sectors."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025